Ultra Petroleum Corp. (NYSE:UPL) reported that its fourth quarter of 2014 net income surged to $209.73 million from $41.12 million last year. Earnings per share jumped to $1.36 from $0.27 in the prior year. The latest-quarter results included unrealized gain of $103.45 million on commodity derivatives. Adjusted earnings per share increased to $0.62 from $0.44 in the previous year. Total operating revenues for the quarter grew to $319.05 million from $225.20 million in the prior year. On Thursday shares of Ultra Petroleum Corp. (NYSE:UPL) closed at $16.22. Company’s sales growth for last 5 years was -3.00% and EPS growth for next 5 years is recorded as 4.73%.
Diplomat Pharmacy, Inc. (NYSE:DPLO) announced Thursday a definitive agreement whereby the company will acquire BioRx, LLC. Diplomat Pharmacy, Inc. (NYSE:DPLO) in last trading activity advanced 17.91% to close at $30.09. Company weekly performance is 15.78% while its quarterly performance stands at 8.67%. Diplomat Pharmacy, Inc. (NYSE:DPLO) is -7.70% away from its 52 week high.
On 24 February 2015, Rockwell Collins Inc. (NYSE:COL) and Advanced Military Maintenance Repair and Overhaul Center (AMMROC) LLC, an Abu Dhabi-based company, have agreed in principle to form a strategic alliance that will provide maintenance, repair and overhaul (MRO) services for military avionics. Target markets include the UAE and countries in the South Asia, Middle East and North Africa (SAMENA) region. On last trading day Rockwell Collins Inc. (NYSE:COL) fell -0.65% to close at $89.34. Its volatility for the week is 1.38% while volatility for the month is 1.24%. COL’s sales growth for past 5 years was 2.40% and its EPS growth for past 5 years was 4.10%. Rockwell Collins Inc. (NYSE:COL) monthly performance is 3.90%.
BlackBerry Ltd (NASDAQ:BBRY) said Wednesday that it has teamed with Google to secure and manage phones equipped with Google’s enterprise platform, Android For Work. On Thursday shares of BlackBerry Ltd (NASDAQ:BBRY) closed at $10.76. Company’s sales growth for last 5 years was -9.20% and EPS growth for next 5 years is recorded as 54.20%.
Analysts at Stifel Nicolaus hoisted their target price on shares of FactSet Research Systems Inc. (NYSE:FDS) from $153.00 to $175.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. On last trading day FactSet Research Systems Inc. (NYSE:FDS) fell -0.88% to close at $155.88. Its volatility for the week is 1.32% while volatility for the month is 1.54%. FDS’s sales growth for past 5 years was 8.20% and its EPS growth for past 5 years was 10.60%. FactSet Research Systems Inc. (NYSE:FDS) monthly performance is 7.14%.